RLYB

Conviction 82HealthcareScan · Mon, Aug 10, 2026

RLYB$16.68+3.19%

ResistanceSupportVol 14Insider buy

Vol MA14 28.1K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Rallybio CorpPHARMACEUTICAL PREPARATIONSwww.rallybio.com ↗

Price16.68

Change+3.19%

Gap+1.61%

Rel volume1.44×

Avg volume38.13K

Avg $ vol619.65K

SMA 2016.25

SMA 5016.03

SMA 2007.93

Price vs 50+4.01%

Price vs 200+110.19%

MA stackbullish

50/200 cross—

Supertrendup · 15.24

RSI (14)64

MACD hist-0.01

MACD cross—

Stoch %K / %D73 / 43

ADX (14)35

+DI / −DI25 / 8

RSI divergence—

MACD divergence—

ATR %+2.87%

ADR %2.99%

52w high16.91

52w low0.4970

From 52w high-1.39%

Above 52w low+3255.13%

New 52w highNo

SqueezeOn · 30d

Bollinger width6.97%

%B0.88

Donchian pos69.49%

Donchian high17.09

Donchian low15.73

AVWAP (52w high)16.26

vs AVWAP high+2.58%

AVWAP (52w low)5.80

vs AVWAP low+187.48%

OBV trendUp

Chaikin MF (20)-0.09

Today vs 20d1.44×

Avg vol (14d)28.1K

Avg vol (20d)38.13K

Avg $ vol (20d)619.65K

Market cap88.55M

RS 3m (vs SPY)+4.53%

RS 6m (vs SPY)+2665.38%

RS line new highNo

Trend template8/8

Technical rank88.4

1 week+4.55%

1 month+6.01%

3 months+15.96%

6 months+251.05%

1 year+3163.21%

YTD+2257.56%

P/E-9.86

P/B0.94

P/S103.21

P/FCF-2.97

EPS-1.59

Div yield—

ROE-9.50%

ROA-9.16%

Debt/Eq—

Current27.26

EV/EBITDA0.13

Gross margin—

Net margin—

Rev growth34.91%

EPS growth84.46%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-4.3M

Revenue0

Net income43.66M

Gross profit—

Free cash flow-29.81M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees9

ListedThu, Jul 29, 2021

Free float1.97M

Float %37.2%

Short interest170.16K

Days to cover3.5d

Short volume37.3%

Squeeze score42 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction82 / 100

Pattern quality—

Tech rank88.4 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance17.04

Support15.64

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RLYB

All disclosures →

No recent disclosed trades by Congress in RLYB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RLYB · 9 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Boudreau Helen M Director · Option (Right to Buy) · 2026-07-06	Exercise	3.56K	—	2026-07-06	2026-07-10
Boudreau Helen M Director · Common Stock · 2026-07-06	Exercise	3.56K	$8K	2026-07-06	2026-07-10
ADAR1 Capital Management, LLC 10% owner · Common Stock · 2026-05-19	Buy	200	$3K	2026-05-19	2026-05-20
ADAR1 Capital Management, LLC 10% owner · Common Stock · 2026-05-19	Buy	10K	$140K	2026-05-19	2026-05-20
Schneeberger Daniel 10% owner · Common Stock · 2026-05-19	Buy	200	$3K	2026-05-19	2026-05-20
Schneeberger Daniel 10% owner · Common Stock · 2026-05-19	Buy	10K	$140K	2026-05-19	2026-05-20
ADAR1 Capital Management, LLC 10% owner · Common Stock · 2026-05-18	Buy	6.01K	$84K	2026-05-18	2026-05-20
Schneeberger Daniel 10% owner · Common Stock · 2026-05-18	Buy	6.01K	$84K	2026-05-18	2026-05-20
ADAR1 Capital Management, LLC 10% owner · Common Stock · 2026-05-15	Buy	100	$1K	2026-05-15	2026-05-15
Schneeberger Daniel 10% owner · Common Stock · 2026-05-15	Buy	100	$1K	2026-05-15	2026-05-15

SEC filings

EDGAR filings in RLYB · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.